Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms

Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms

Anti-gp210 is the disease-specific anti-nuclear antibody (ANA) of primary biliary cholangitis (PBC). Anti-gp210-positive PBC patients have worse responses to ursodeoxycholic acid (UDCA) as compared with anti-gp210-negative patients. Moreover, anti-gp210-positive patients always present with more sev...

Full description

Bibliographic Details
Main Authors: Xiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Annals of Hepatology
Subjects:
Anti-gp210
Primary biliary cholangitis
Treatment response
Pathogenesis
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268123002259

Internet

http://www.sciencedirect.com/science/article/pii/S1665268123002259

Similar Items